274 related articles for article (PubMed ID: 31994353)
1. Osmotic diuresis by SGLT2 inhibition stimulates vasopressin-induced water reabsorption to maintain body fluid volume.
Masuda T; Muto S; Fukuda K; Watanabe M; Ohara K; Koepsell H; Vallon V; Nagata D
Physiol Rep; 2020 Jan; 8(2):e14360. PubMed ID: 31994353
[TBL] [Abstract][Full Text] [Related]
2. SGLT2 inhibitor and loop diuretic induce different vasopressin and fluid homeostatic responses in nondiabetic rats.
Masuda T; Ohara K; Vallon V; Nagata D
Am J Physiol Renal Physiol; 2022 Sep; 323(3):F361-F369. PubMed ID: 35900341
[TBL] [Abstract][Full Text] [Related]
3. Unmasking a sustained negative effect of SGLT2 inhibition on body fluid volume in the rat.
Masuda T; Watanabe Y; Fukuda K; Watanabe M; Onishi A; Ohara K; Imai T; Koepsell H; Muto S; Vallon V; Nagata D
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F653-F664. PubMed ID: 29790389
[TBL] [Abstract][Full Text] [Related]
4. Effects of SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone on fluid retention in type 2 diabetic mice with NASH.
Tahara A
Eur J Pharmacol; 2021 Jun; 901():174076. PubMed ID: 33798599
[TBL] [Abstract][Full Text] [Related]
5. The Sodium Glucose Cotransporter 2 Inhibitor Ipragliflozin Promotes Preferential Loss of Fat Mass in Non-obese Diabetic Goto-Kakizaki Rats.
Takasu T; Hayashizaki Y; Hirosumi J; Minoura H; Amino N; Kurosaki E; Takakura S
Biol Pharm Bull; 2017; 40(5):675-680. PubMed ID: 28458353
[TBL] [Abstract][Full Text] [Related]
6. SGLT2 inhibition in a kidney with reduced nephron number: modeling and analysis of solute transport and metabolism.
Layton AT; Vallon V
Am J Physiol Renal Physiol; 2018 May; 314(5):F969-F984. PubMed ID: 29361669
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent effects of ipragliflozin on behaviour and energy homeostasis in normal and type 2 diabetic rats: continuous glucose telemetry analysis.
Iuchi H; Sakamoto M; Matsutani D; Suzuki H; Kayama Y; Takeda N; Minamisawa S; Utsunomiya K
Sci Rep; 2017 Sep; 7(1):11906. PubMed ID: 28928461
[TBL] [Abstract][Full Text] [Related]
8. Water Conservation Overrides Osmotic Diuresis During SGLT2 Inhibition in Patients With Heart Failure.
Marton A; Saffari SE; Rauh M; Sun RN; Nagel AM; Linz P; Lim TT; Takase-Minegishi K; Pajarillaga A; Saw S; Morisawa N; Yam WK; Minegishi S; Totman JJ; Teo S; Teo LLY; Ng CT; Kitada K; Wild J; Kovalik JP; Luft FC; Greasley PJ; Chin CWL; Sim DKL; Titze J
J Am Coll Cardiol; 2024 Apr; 83(15):1386-1398. PubMed ID: 38599715
[TBL] [Abstract][Full Text] [Related]
9. Sodium glucose co-transporter 2 inhibitors and their mechanism for improving glycemia in patients with type 2 diabetes.
Davidson JA; Kuritzky L
Postgrad Med; 2014 Oct; 126(6):33-48. PubMed ID: 25414933
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of renal and cardiovascular protection mechanisms of SGLT2 inhibitors: model-based analysis of clinical data.
Hallow KM; Greasley PJ; Helmlinger G; Chu L; Heerspink HJ; Boulton DW
Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1295-F1306. PubMed ID: 30019930
[TBL] [Abstract][Full Text] [Related]
11. First-dose effect of the SGLT2 inhibitor ipragliflozin on cardiovascular activity in spontaneously diabetic Torii fatty rats.
Takakura S; Takasu T
Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):266-273. PubMed ID: 30485488
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo.
Tahara A; Kurosaki E; Yokono M; Yamajuku D; Kihara R; Hayashizaki Y; Takasu T; Imamura M; Qun L; Tomiyama H; Kobayashi Y; Noda A; Sasamata M; Shibasaki M
Naunyn Schmiedebergs Arch Pharmacol; 2012 Apr; 385(4):423-36. PubMed ID: 22139434
[TBL] [Abstract][Full Text] [Related]
13. SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats.
Yokono M; Takasu T; Hayashizaki Y; Mitsuoka K; Kihara R; Muramatsu Y; Miyoshi S; Tahara A; Kurosaki E; Li Q; Tomiyama H; Sasamata M; Shibasaki M; Uchiyama Y
Eur J Pharmacol; 2014 Mar; 727():66-74. PubMed ID: 24486393
[TBL] [Abstract][Full Text] [Related]
14. Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan.
Ohara K; Masuda T; Murakami T; Imai T; Yoshizawa H; Nakagawa S; Okada M; Miki A; Myoga A; Sugase T; Sekiguchi C; Miyazawa Y; Maeshima A; Akimoto T; Saito O; Muto S; Nagata D
Nephrology (Carlton); 2019 Sep; 24(9):904-911. PubMed ID: 30578654
[TBL] [Abstract][Full Text] [Related]
15. SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1.
Novikov A; Fu Y; Huang W; Freeman B; Patel R; van Ginkel C; Koepsell H; Busslinger M; Onishi A; Nespoux J; Vallon V
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F173-F185. PubMed ID: 30427222
[TBL] [Abstract][Full Text] [Related]
16. A role for tubular Na
Onishi A; Fu Y; Patel R; Darshi M; Crespo-Masip M; Huang W; Song P; Freeman B; Kim YC; Soleimani M; Sharma K; Thomson SC; Vallon V
Am J Physiol Renal Physiol; 2020 Oct; 319(4):F712-F728. PubMed ID: 32893663
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic and antiobesity effects of SGLT2 inhibitor ipragliflozin in type 2 diabetic mice fed sugar solution.
Tahara A; Takasu T; Yokono M; Imamura M; Kurosaki E
Eur J Pharmacol; 2018 Jan; 818():545-553. PubMed ID: 29154936
[TBL] [Abstract][Full Text] [Related]
18. Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.
Rieg T; Masuda T; Gerasimova M; Mayoux E; Platt K; Powell DR; Thomson SC; Koepsell H; Vallon V
Am J Physiol Renal Physiol; 2014 Jan; 306(2):F188-93. PubMed ID: 24226519
[TBL] [Abstract][Full Text] [Related]
19. Acute and Direct Effects of Sodium-Glucose Cotransporter 2 Inhibition on Glomerular Filtration Rate in Spontaneously Diabetic Torii Fatty Rats.
Takakura S; Takasu T
Biol Pharm Bull; 2019; 42(10):1707-1712. PubMed ID: 31582658
[TBL] [Abstract][Full Text] [Related]
20. Evidence against bicarbonate reabsorption in the ascending limb, particularly as disclosed by free-water clearance studies.
Seldin DW; Rosin JM; rector FC
Yale J Biol Med; 1975 Sep; 48(4):337-47. PubMed ID: 1202762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
